Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHIP Trial
NCT07652528Not yet recruiting
- Sponsor
- Hallym University
- Start
- Aug 2026
- Primary completion
- Jun 2028
01
Overview
Randomised, open-label trial (2 arms), sponsored by Hallym University. Primary endpoint: 24-hour CGM Time Above Range >180 mg/dL at 9 days. Planned start Aug 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07652528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07652528.